Download presentation
Presentation is loading. Please wait.
1
Selecting and Applying Chemotherapy
3
Introduction: Discussion Topic
4
The Role of Chemotherapy in MBC
5
ABC 3 Guidelines: Factors Influencing Treatment Choice
6
Monotherapy vs Combination Chemotherapy
7
Duration of Chemotherapy
8
Optimal Duration of Chemotherapy?
9
Main Goals in the Treatment of MBC
10
International Guidelines Regarding the Role of Chemotherapy in MBC
11
Choice of First-line Chemotherapy in HER2-Negative MBC
12
Which Chemotherapy Regimen?
13
HERNATA: Vinorelbine in HER2-positive MBC
14
Phase 2 NorBreast-231 Trial: Clinical Activity in the ITT Population
15
Hematological Toxicities: Worst Grade
16
Nonhematological Toxicities: Worst Grade
17
Phase 2 NorBreast-231 Trial: OS
18
Considerations for Oral CT for MBC
19
Managing TEAEs Related to Oral Vinorelbine
20
Metronomic CT
21
Oral Vinorelbine in the First-line Setting for MBC and NSCLC: The Chinese Experience
22
Oral Vinorelbine in the First-line Setting for MBC and NSCLC: Results
23
Potential Benefit of Oral Vinorelbine in China
24
Conclusions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.